Nieuwenhuis, Bart https://orcid.org/0000-0002-2065-2271
Barber, Amanda C
Evans, Rachel S
Pearson, Craig S
Fuchs, Joachim
MacQueen, Amy R
van Erp, Susan https://orcid.org/0000-0003-0883-2795
Haenzi, Barbara
Hulshof, Lianne A
Osborne, Andrew
Conceicao, Raquel
Khatib, Tasneem Z
Deshpande, Sarita S
Cave, Joshua
Ffrench‐Constant, Charles
Smith, Patrice D
Okkenhaug, Klaus https://orcid.org/0000-0002-9432-4051
Eickholt, Britta J
Martin, Keith R
Fawcett, James W https://orcid.org/0000-0002-7990-4568
Eva, Richard https://orcid.org/0000-0003-0305-0452
Funding for this research was provided by:
MRC Sackler
International Spinal Research Trust (NRB110)
Wellcome Trust (095691/Z/11/Z)
ERA-NET Neuron grant AxonRepair
UK Research and Innovation, Medical Research Council (MR/R004544/1)
UK Research and Innovation, Medical Research Council (MR/R004463/1)
Multiple Sclerosis Society
Christopher and Dana Reeve Foundation
Cambridge Eye Trust
Fight for Sight UK (5065/5066)
Fight for Sight UK (5119/5120)
National Eye Research Centre
Deutsche Forschungsgemeinschaft (SFB 958)
Deutsche Forschungsgemeinschaft (TP16)
Deutsche Forschungsgemeinschaft (SFB TRR 186)
Deutsche Forschungsgemeinschaft (TP10)
UK Research and Innovation Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0409)
UK Research and Innovation Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0427)
Czech Ministry of Education, Centre of Reconstructive Neuroscience (CZ.02.1.01/0.0./0.0/15_003/0000419)
European Molecular Biology Organization (ALTF 1436-2015)
Article History
Received: 4 November 2019
Revised: 27 May 2020
Accepted: 29 May 2020
First Online: 17 June 2020
Conflict of interest
: KO received consultancy payments and/or research funding from Karus Therapeutics, Gilead Sciences and GlaxoSmithKline.